Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
Chinese funds pour US$1.4b into US biotechnology firms in the first three months of the year
It’s unclear whether a deepening trade rift with the US could slow the stream of cash from China to medical innovation hubs such as Silicon Valley and Cambridge, Massachusetts
Topic |
Pharmaceuticals
Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters